Allium Group Receives CE Mark For Its Next-Generation Prostatic Stent (Medical News Today) PDF Print

Allium Group, the developer and manufacturer of innovative stents for the urinary, gastro-intestinal, pulmonary and peripheral vascular tracts, announced today that it has been awarded CE mark for its prostatic stent enabling commercialization of the system in the European Union and the countries that recognize the CE Mark.

read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.